Associate ProfessorMcGill University, Canada
Disclosure information not submitted.
SP06A - Comparative Effectiveness and Safety of Apixaban versus Rivaroxaban Among Patients with Non-valvular Atrial Fibrillation and Liver Disease: A Population-based Cohort Study
Tuesday, August 24, 20213:30 PM – 4:45 PM US Eastern Time